脓毒症与地方性及新发传染病:概念融合与临床启示
本文为Lancet Infect Dis的个人观点文章,讨论脓毒症与疟疾、钩端螺旋体病、结核、胃肠炎等地方性及新发传染病之间的概念重叠。全球脓毒症负担研究显示85%的病例和死亡发生在低收入和中等收入国家。作者提出对这类疾病采用疾病特异性分层,区分轻症与伴器官功能障碍的危及生命形式(SEEID),并呼吁早期识别及疾病特异性专家指导。
要点
- 全球脓毒症病例和死亡的85%发生在低收入和中等收入国家。
- 脓毒症与地方性及新发传染病概念重叠,但临床轨迹与诊治路径存在重要差异。
- 建议对地方性及新发传染病进行疾病特异性分层,识别伴器官功能障碍的SEEID。
核心结论
- 全球脓毒症负担研究证实其高死亡率、高致残率和社会影响,且模糊了脓毒症与地方性及新发传染病之间的界限。
- 将疾病特异性死亡置于脓毒症框架下,凸显资源有限地区可预防、可治疗地方性传染病死亡率高得不可接受。
- 脓毒症管理与地方性及新发传染病诊治重点不同,前者强调早期诊断、及时干预、器官支持及精准靶向治疗。
研究设计与样本
- 本文为Personal View(个人观点)文章,非系统检索或临床试验。
- 基于全球脓毒症负担研究及疟疾、钩端螺旋体病、结核、胃肠炎等疾病的相关证据进行概念分析。
主要发现
- 85%的脓毒症病例和死亡发生在低收入和中等收入国家。
- 疟疾、钩端螺旋体病、结核和胃肠炎等疾病的临床轨迹常不同于所谓标准脓毒症。
- 地方性及新发传染病常在入院前经历漫长而复杂的病程,需要疾病特异性诊断和治疗。
- 评估这些疾病治疗策略的随机临床试验稀缺。
关键数值与推荐
- 脓毒症定义为宿主对感染反应失调导致危及生命的器官功能障碍。
- 提出SEEID概念,即地方性及新发传染病所致脓毒症,用以区分轻症与伴器官功能障碍的危及生命形式。
临床怎么用
- 临床应早期识别和诊断SEEID,并对地方性及新发传染病进行疾病特异性分层。
- 脓毒症管理侧重早期诊断、及时干预和器官支持,地方性及新发传染病需疾病特异性诊治路径。
- 亟需疾病特异性专家指导,尤其因相关随机临床试验稀缺。
局限性
- 本文为个人观点文章,未提供原始研究数据或系统评价。
- 原文未报告具体样本量、阈值或疗效数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Studies on the global burden of sepsis confirm its major mortality, morbidity, and societal impact, with 85% of cases and deaths occurring in low-income and middle-income countries. Importantly, these analyses have blurred the boundaries between sepsis, defined as a dysregulated host response to infection causing life-threatening organ dysfunction, and endemic and emerging infectious diseases, such as malaria, leptospirosis, tuberculosis, and gastroenteric illnesses, which often follow clinical trajectories distinct from those of so-called standard sepsis. Framing these disease-specific deaths within the broader context of sepsis highlights the unacceptably high mortality from preventable and treatable endemic infectious diseases in resource-limited settings. However, important differences remain. Sepsis management focuses on early diagnosis, timely intervention, organ support, and, increasingly, patient stratification and precision-targeted therapies. In contrast, endemic and emerging infectious diseases often involve lengthy and complex courses before hospital admission and require disease-specific diagnostic and therapeutic approaches. In this Personal View, we discuss how this conceptual overlap affects estimates of disease burden, interpretation of pathophysiological mechanisms, therapeutic decision making, and the development of precision medicine strategies. We propose applying disease-specific stratification to endemic and emerging infectious diseases to distinguish milder cases from life-threatening forms associated with organ dysfunction (sepsis from an endemic and emerging infectious disease [SEEID]). Early recognition and diagnosis of SEEIDs are essential, and expert disease-specific guidance is urgently needed, particularly given the scarcity of randomised clinical trials evaluating treatment strategies for these conditions.
引用
- Salomão R, Leite GGF, Salomão MC, et al. Sepsis, endemic and emerging infectious diseases: converging concepts and clinical implications. Lancet Infect Dis. 2026. PMID: 42685734. doi:10.1016/S1473-3099(26)00373-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。